Molecular Templates (MTEM)
(Delayed Data from NSDQ)
$1.35 USD
-0.01 (-0.74%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.35 0.00 (0.00%) 5:06 PM ET
NA Value
NA Growth NA Momentum NA VGMAverage Brokerage Rating
Current ABR | NA |
ABR (Last week) | NA |
# of Recs in ABR | NA |
Average Target Price | NA |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 82 of 253 |
Current Quarter EPS Est: | NA |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | NA | NA | NA | NA | 1 |
Buy | NA | NA | NA | NA | 0 |
Hold | NA | NA | NA | NA | 0 |
Sell | NA | NA | NA | NA | 0 |
Strong Sell | NA | NA | NA | NA | 0 |
ABR | NA | NA | NA | NA | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
Not Identified | Not Identified | Not Identified | Not Identified | Not Identified |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.